Bhere, Deepak
Arghiani, Nahid
Lechtich, Esther Revai
Yao, Yizheng
Alsaab, Sarah
Bei, Fengfeng
Matin, Maryam M.
Shah, Khalid
Article History
Received: 15 September 2019
Accepted: 9 January 2020
First Online: 4 February 2020
Change Date: 3 July 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41598-024-66236-1
Competing interests
: K.S. owns equity in and is a member of the Board of Directors, AMASA Therapeutics, Inc., a company developing cell-based therapies for cancer. K.S.’s interests were reviewed and are managed by Brigham and Women’s Hospital and Partners HealthCare in accordance with their conflict of interest policies. D.B. is a consultant at AMASA Therapeutics. No potential conflicts of interest were disclosed by the other authors.